<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04788589</url>
  </required_header>
  <id_info>
    <org_study_id>20030379</org_study_id>
    <nct_id>NCT04788589</nct_id>
  </id_info>
  <brief_title>Sedation and Ventilator Weaning Protocol in PICU</brief_title>
  <official_title>Effectiveness of Sedation and Ventilator Weaning Protocol - a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indonesia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indonesia University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This research is a single-blinded, randomized controlled trial involving mechanically&#xD;
      ventilated children in Pediatric Intensive Care Unit, Cipto Mangunkusumo Hospital, Indonesia.&#xD;
      Subjects were divided into two groups: intervention vs control group. Primary and secondary&#xD;
      outcomes will be measure pre, during, and post treatment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      As of today, there is no sedation and ventilator weaning protocol in our PICU. Decision for&#xD;
      sedation and ventilator weaning were based on attending physicians clinical judgement, which&#xD;
      greatly varies among individual. Previous study on the use of these protocols showed a&#xD;
      favorable outcome. We aim to assess the safety and effectiveness of this protocol in our&#xD;
      PICU.&#xD;
&#xD;
      Subjects were recruited consecutively and randomized into intervention and control group.&#xD;
&#xD;
        -  Intervention group: sedation and ventilator weaning protocol&#xD;
&#xD;
        -  Control group: no protocol&#xD;
&#xD;
      Primary outcomes:&#xD;
&#xD;
        -  FLACC score&#xD;
&#xD;
        -  COMFORT score&#xD;
&#xD;
        -  Ventilator days&#xD;
&#xD;
      Secondary outcomes:&#xD;
&#xD;
        -  Self extubation&#xD;
&#xD;
        -  Reintubation&#xD;
&#xD;
        -  PICU Length of stay&#xD;
&#xD;
        -  Frequency of asynchrony&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">December 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Face, Leg, Activity, Cry, Consolability (FLACC) score hour 0</measure>
    <time_frame>every 6 hours for the first 24 hours, once daily until extubation. This is the baseline. Once the patient was intubated, FLACC scoring of hour 0 will be assessed and noted.</time_frame>
    <description>Pain scoring. Each characteristic has 0-2 points with maximum 10 points. The greater number indicate greater pain score.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Face, Leg, Activity, Cry, Consolability (FLACC) score hour 6</measure>
    <time_frame>FLACC scoring of hour 6 will be measured 6 hours after hour 0 was measured. Hour 6 is measured from the time the subject was intubated.</time_frame>
    <description>Pain scoring. Each characteristic has 0-2 points with maximum 10 points. The greater number indicate greater pain score.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Face, Leg, Activity, Cry, Consolability (FLACC) score hour 12</measure>
    <time_frame>FLACC scoring of hour 12 will be measured 12 hours after hour 0 was measured. Hour 12 is measured from the time the subject was intubated.</time_frame>
    <description>Pain scoring. Each characteristic has 0-2 points with maximum 10 points. The greater number indicate greater pain score.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Face, Leg, Activity, Cry, Consolability (FLACC) score hour 18</measure>
    <time_frame>FLACC scoring of hour 18 will be measured 18 hours after hour 0 was measured. Hour 18 is measured from the time the subject was intubated.</time_frame>
    <description>Pain scoring. Each characteristic has 0-2 points with maximum 10 points. The greater number indicate greater pain score.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Face, Leg, Activity, Cry, Consolability (FLACC) score day 1 until extubation</measure>
    <time_frame>Scoring will be assessed every morning. If the subject was intubated at night, scoring for day 1 will be measured in the morning the day after tomorrow. Thereafter, the measurement will be taken every morning, 24 hour apart until the subject extubation.</time_frame>
    <description>Pain scoring. Each characteristic has 0-2 points with maximum 10 points. The greater number indicate greater pain score.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Face, Leg, Activity, Cry, Consolability (FLACC) score extubation day</measure>
    <time_frame>This score will be taken when the subject was stopped from all sedative and analgetics, just before extubation. Monitoring of extubation will be conducted until 56 days after initial intubation.</time_frame>
    <description>Pain scoring. Each characteristic has 0-2 points with maximum 10 points. The greater number indicate greater pain score.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>COMFORT score hour 0</measure>
    <time_frame>This is the baseline. Once the patient was intubated, COMFORT scoring of hour 0 will be assessed and noted.</time_frame>
    <description>Sedation scoring. It consists of 8 components. Each component has a score of 1-5, max score 40. Scores of 8 - 17 are over-sedated, scores between 17 - 26 are adequately sedated, and scores between 27 - 40 are under-sedated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>COMFORT score hour 6</measure>
    <time_frame>COMFORT scoring of hour 6 will be measured 6 hours after hour 0 was measured. Hour 6 is measured from the time the subject was intubated.</time_frame>
    <description>Sedation scoring. It consists of 8 components. Each component has a score of 1-5, max score 40. Scores of 8 - 17 are over-sedated, scores between 17 - 26 are adequately sedated, and scores between 27 - 40 are under-sedated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>COMFORT score hour 12</measure>
    <time_frame>COMFORT scoring of hour 12 will be measured 12 hours after hour 0 was measured. Hour 12 is measured from the time the subject was intubated.</time_frame>
    <description>Sedation scoring. It consists of 8 components. Each component has a score of 1-5, max score 40. Scores of 8 - 17 are over-sedated, scores between 17 - 26 are adequately sedated, and scores between 27 - 40 are under-sedated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>COMFORT score hour 18</measure>
    <time_frame>COMFORT scoring of hour 18 will be measured 18 hours after hour 0 was measured. Hour 18 is measured from the time the subject was intubated.</time_frame>
    <description>Sedation scoring. It consists of 8 components. Each component has a score of 1-5, max score 40. Scores of 8 - 17 are over-sedated, scores between 17 - 26 are adequately sedated, and scores between 27 - 40 are under-sedated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>COMFORT score day 1 until extubation</measure>
    <time_frame>Scoring will be assessed every morning. If the subject was intubated at night, scoring for day 1 will be measured in the morning the day after tomorrow. Thereafter, the measurement will be taken every morning, 24 hour apart until the subject extubation.</time_frame>
    <description>Sedation scoring. It consists of 8 components. Each component has a score of 1-5, max score 40. Scores of 8 - 17 are over-sedated, scores between 17 - 26 are adequately sedated, and scores between 27 - 40 are under-sedated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>COMFORT score extubation day</measure>
    <time_frame>This score will be taken when the subject was stopped from all sedative and analgetics, just before extubation. Monitoring of extubation will be conducted until 56 days after initial intubation.</time_frame>
    <description>Sedation scoring. It consists of 8 components. Each component has a score of 1-5, max score 40. Scores of 8 - 17 are over-sedated, scores between 17 - 26 are adequately sedated, and scores between 27 - 40 are under-sedated</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ventilator time</measure>
    <time_frame>From intubation to extubation which would not need reintubation within 48 hours of extubation, measurement of the time frame may be assessed up to 28 days measured from intubation time.</time_frame>
    <description>Time to extubation (days)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reintubation frequency</measure>
    <time_frame>Frequency of subject who are extubated to be reintubated within 48 hours after extubation. Assessment will be noted up to 28 days measured from the first time intubation was performed.</time_frame>
    <description>Number of times subject was reintubated within 48 hours after extubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self extubation frequency</measure>
    <time_frame>Frequency of self extubation by the patient during one episode of intubation. Assessment will be noted up to 28 days measured from the first time intubation was performed.</time_frame>
    <description>Number of times subject was self extubated during one episode of intubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PICU length of stay</measure>
    <time_frame>Length of stay in PICU from admission until patient's death or step-down to the pediatric ward. Assessment of PICU length of stay will be noted up to 56 days measured from the first day of PICU admission as day 1.</time_frame>
    <description>Days from PICU admission to death or move outside the PICU to the ward</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Mechanical Ventilation</condition>
  <condition>Sedation</condition>
  <arm_group>
    <arm_group_label>Sedation and Ventilator Weaning Protocol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sedation: start midazolam 5-10 mins (max 3x). If MV 12 hrs-2d: Pain: morphine @2 hrs if needed (max 10mg/x). Sedation: midazolam @ 1-2 hrs if needed (max 10mg/x). If MV &gt;2 d: morphine &amp; midazolam drip (max 10mg/hr). MV weaning checklist @morning. Pass if no incr of sedation dose due to agitation, NMBAs, incr in ICP. Fail: reassessed tomorrow. Pain and SBS scores assessed @morning until extubation. Stop all sedation and analgetic for sedation. Continue analgetics for pain. Subjects monitored for 4 hrs. Assess pain and WAT-1 score. Pass (GCS of E3, tolerate sedation interruption for &gt; 4 hrs): MV weaning protocol. Fail (Persistent anxiety/agitation, incr pain score, incr RR &gt; 5 mins, SpO2 &lt;88% &gt;5 mins, acute heart dysrhythmia, &gt;=2 signs of ARDS): sedation resumed Â½ dose, up titrated.&#xD;
MV weaning: CPAP 5/PS &lt; 7. Pass: No failure criteria for 2 hrs. Fail (Incr RR &gt; 5 mins, SpO2 &lt;88% &gt; 5 mins, acute decr in GCS/acute heart dysrhythmia, &gt;=2 signs of ARDS): previous MV setting.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Informed consent&#xD;
Randomization into groups&#xD;
Sedation and ventilator weaning according to attending physicians&#xD;
Pain scores and SBS score is noted every 6 hours for the first 24 hours, and every day for the next 24 hours until extubation.&#xD;
Attending physicians assessed that subject could be weaned: pain scores, SBS score, WAT-1 score&#xD;
Extubation. Researcher did not take part in the judgement of extubation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sedation and ventilator weaning protocol</intervention_name>
    <description>Subjects randomized to this group will underwent sedation and ventilator weaning protocol as mentioned before.</description>
    <arm_group_label>Sedation and Ventilator Weaning Protocol</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient who need mechanical ventilation for more than 12 hours&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  PICU admission due to post cardiac and respiratory arrest&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gryselda Hanafi, MD</last_name>
    <phone>628170113134</phone>
    <email>gryseldahanafi@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Antonius Hocky Pudjiadi, MD, PhD</last_name>
    <email>ahpdujiadi@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cipto Mangunkusumo Hospital</name>
      <address>
        <city>Jakarta Pusat</city>
        <state>DKI Jakarta</state>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gryselda Hanafi, MD</last_name>
      <phone>628170113134</phone>
      <email>gryseldahanafi@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Antonius H Pudjiadi, MD, PhD</last_name>
      <email>ahpudjiadi@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Antonius H Pudjiadi, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tartila Tartila, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fatima Safira Alatas, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 13, 2021</study_first_submitted>
  <study_first_submitted_qc>March 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 9, 2021</study_first_posted>
  <last_update_submitted>March 10, 2021</last_update_submitted>
  <last_update_submitted_qc>March 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indonesia University</investigator_affiliation>
    <investigator_full_name>Dr. dr. Antonius Hocky Pudjiadi, SpA(K)</investigator_full_name>
    <investigator_title>Principal Investigator, Head of Pediatric Intensive Care Unit</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

